Common and Preferred Stock Reserved for Future Issuances:
 6 Months Ended 12 Months Ended
Jun. 30, 2016
Dec. 31, 2015
Common And Preferred Stock Reserved For Future Issuances [Abstract]    
Common And Preferred Stock Reserved For Future Issuances [Text Block]
Note 10 – Common and Preferred Stock Reserved for Future Issuances:
 
Common stock reserved for future issuances consisted of the following at June 30, 2016:
 
 
 
Common
Stock
 Reserved
 
Common stock warrants outstanding
 
 
134,800,876
 
Common stock for potential anti-dilution of warrants
 
 
66,712,722
 
Common stock options outstanding
 
 
8,832,534
 
Conversion of Series B Stock
 
 
25,804,940
 
Common stock for potential anti-dilution of Series B Stock
 
 
12,902,470
 
Total
 
 
249,053,542
 
 
On February 9, 2015, the holders of placement agent warrants to purchase an aggregate of 1,325,000 shares of our Series A Stock entered into Conversion Agreements with the Company pursuant to which such holders’ placement agent warrants to purchase Series A Stock were converted, for no additional consideration, into common stock purchase warrants to purchase an aggregate of 1,325,000 shares of Common Stock.
 
Resulting from the Private Placement, the Company is required to reserve shares of its common stock to accommodate up to an additional 50% issuable upon potential dilution to the Series B Stock and all the Series A through E Warrants issued in the Private Placement plus the placement agent warrants issued as fees relating to the Private Placement.
Note 11 – Common and Preferred Stock Reserved for Future Issuances:
 
Common stock reserved for future issuances consisted of the following at December 31, 2015:
 
 
 
Common
Stock
Reserved
 
Common stock warrants outstanding
 
 
134,828,240
 
Common stock for potential anti-dilution of warrants
 
 
67,288,955
 
Common stock options outstanding
 
 
8,582,952
 
Conversion of Series B Stock
 
 
26,234,940
 
Common stock for potential anti-dilution of Series B Stock
 
 
13,117,470
 
Total
 
 
250,052,557
 
 
On February 9, 2015, the holders of placement agent warrants to purchase an aggregate of 1,325,000 shares of our Series A Stock entered into Conversion Agreements with us pursuant to which such holders’ placement agent warrants to purchase Series A Stock were converted, for no additional consideration, into common stock purchase warrants to purchase an aggregate of 1,325,000 shares of our common stock.
 
Resulting from the November 2015 Private Placement, the Company is required to reserve shares of its common stock to accommodate up to an additional 50% issuable upon potential dilution to the Series B Stock and all the Series A through E Warrants issued in the November 2015 Private Placement plus the placement agent warrants issued as fees relating to the November 2015 Private Placement.